Brad Rice
Education
Ph.D., economics, and M.A., political economy, Boston University; B.A., economics, University of Florida
Summary of Experience
Dr. Rice is an economist with a range of expertise in health economics, industrial organization, finance, statistics, and econometrics. He has extensive experience applying economic theory and statistical methods in complex litigation and research settings. Dr. Rice has led analyses related to government investigations and litigation matters, where he has supported counsel and served as an expert on alleged False Claims Act (FCA) violations, as well as on antitrust, cryptocurrency, insider trading, misappropriation of trade secrets, and breach of contract issues. In matters related to liability and damages, he conducts empirical analyses involving large-scale databases on a range of topics, including causal inference, merger simulation, and lost profits and budget impact. Dr. Rice’s case experience has involved assisting in the preparation of expert reports, testimony, and rebuttal analyses and arguments; developing sophisticated interactive models enabling real-time damages assessments under alternative scenarios; and presenting analyses to US Attorney’s Office investigators. In addition to his litigation work, he has provided econometric and statistical consulting on matters such as risk management, fair market valuation, and compliance. Dr. Rice is an adjunct faculty member of the Harvard University Department of Economics and has taught undergraduate courses on econometrics, health economics, industrial organization, and regulatory economics. He has published extensively in numerous peer-reviewed journals, and presented at conferences and seminars.
-
Prescription Opioid Utilization Patterns, and Associated Outcomes, among Privately-Insured Patients Prescribed Opioids to Manage Pain Associated with Osteoarthritis
Current Medical Research and Opinion, 2023
2023Schepman P, Rice JB, Beck CG, White A, Robinson RL, Thakkar S, Fernan C, Emir B, Silverman S
-
Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis
Advances in Therapy, 2023
2023Hayes K, Niewoehner J, Rice JB, Downes N, Hagopian E, Ma I, Wan GJ
-
Telehealth Growth Trends Highlight Emerging Risks
Law360, June 14, 2021
2021Rotenstein L, Rice B, Kumcu J
-
Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome
Current Medical Research and Opinion, 2021
2021Rice JB, Panaccio MP, White A, Simes M, Billmyer E, Downes N, Niewoehner J, Wan GJ
-
Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Ocular Immunology and Inflammation, 2020
2020Albini TA, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L, Ciepielewska G, Nelson WW
-
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
Neurology and Therapy, 2020
2020Rice JB, Panaccio MP, White A, Simes M, Billmyer E, Downes N, Niewoehner J, Wan GJ
-
Predictors of High-cost Patients With Noninfectious Inflammatory Eye Diseases
Clinical Therapeutics, 2019
2019Nelson WW, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L, Ciepielewska G, Albini TA
-
Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis
Clinical Chemistry and Laboratory Medicine. May 1 2018
2018Hey J, Thompson-Leduc P, Kirson NY, Zimmer L, Wilkins D, Rice B, Iankova I, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P
-
Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population
Journal of Medical Economics. 2018 Sep;21(9):846-852
2018Rice JB, White AG, Johnson M, Wagh A, Qin Y, Bartels-Peculis L, Ciepielewska G, Nelson WW
-
Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population
Current Medical Research and Opinion. 2018 Aug;34(8):1519-1527
2018Rice JB, White AG, Johnson M, Wagh A, Qin Y, Bartels-Peculis L, Ciepielewska G, Nelson WW
-
The burden of non-infectious intraocular inflammatory eye diseases: a systematic literature review
Current Medical Research and Opinion. 2018 Dec;34(12):2095-2103
2018 -
Economic burden of sarcoidosis in a commercially-insured population in the United States
Journal of Medical Economics. Oct 2017;20(10):1048-1055
2017Rice JB, White A, Lopez A, Conway A, Wagh A, Nelson WW, Philbin M, Wan GJ
-
High-cost sarcoidosis patients in the United States: Patient characteristics and patterns of health care resource utilization
Journal of Managed Care and Specialty Pharmacy. 2017;23(12):1261-1269a
2017 -
The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States
Current Medical Research and Opinion. Aug 2017;33(8):1473-1480
2017Rice JB, White AG, Galebach P, Korenblat KM, Wagh A, Lovelace B, Wan GJ, Jamil K
-
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
Clinical Therapeutics. Nov 2017;39(11):2216-2229
2017 -
Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis
Critical Care Medicine. Dec 21 2017
2017Iankova I, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P
-
Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population
Journal of Medical Economics, 2016 07; 19(7): 649-654
2016Rice BJ, White A, Lopez A, Galebach P, Schepman P, Popelar B, Philbin M.
-
Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers
J Med Econ. 2015 Mar 19:1-18
2015Rice B, Desai U, Ristovska L, Cummings AK, Birnbaum HG, Skornicki M, Margolis DJ, Parsons NB
-
The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals
Pain Med. 2015 Apr 30. doi: 10.1111/pme.12768
2015Kirson NY, Shei A, Rice JB, Enloe CJ, Bodnar K, Birnbaum HG, Holly P, Ben-Joseph R
-
Sources of prescription opioids among diagnosed opioid abusers
Curr Med Res Opin. 2015 Apr;31(4):779-84
2015Shei A, Rice JB, Kirson NY, Bodnar K, Birnbaum HG, Holly P, Ben-Joseph R
-
Burden of diabetic foot ulcers for medicare and private insurers
Diabetes Care. 2014 Mar; 37(3):651-8
2014Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB
-
The economic burden of diagnosed opioid abuse among commercially insured individuals
Postgrad Med. 2014 Jul;126(4):53-8
2014Rice JB, Kirson NY, Shei A, Enloe CJ, Cummings AK, Birnbaum HG, Holly P, Ben-Joseph R
-
Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data
Appl Health Econ Health Policy. 2014 Aug;12(4):435-46
2014Rice JB, Kirson NY, Shei A, Cummings AK, Bodnar K, Birnbaum HG, Ben-Joseph R
-
A model to identify patients at risk for prescription opioid abuse, dependence, and misuse
Pain Med. 2012 Sep; 13(9):1162-73
2012Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL
-
A comparative analysis of Medicaid long-term care policies and their effects on elderly dual enrollees
Health Econ. 2009 Mar; 18(3):275-90
2009Rice JB, Kasper JD, Pezzin LE
-
June 26, 2022
-
June 11, 2023
-
March 2, 2023
-
August 12, 2021
-
June 21, 2021